Tag Archives: 2017

Let’s Meet at ibtm world Barcelona and Discuss the Biggest Medical Congresses of 2018

This November, between the 28th and the 30th, Barcelona hosts ibtm world, “the leading global event for the meetings, incentives, conferences, events and business travel industry.”

With a 30-year history, the event was initially named EIBTM. It started out in 1988 in Geneva, Switzerland, and it soon became a global exhibition for those in the meetings, incentives, conferences and events industry. In 2000, EIBTM was acquired by Reed Travel Exhibitions, part of the Reed Elsevier Group in 2000 and moved to Barcelona in 2004.

The three day event offers innovative education sessions, as well as a wide range of networking opportunities that trigger future business growth.

 

Event Attendees

Around 15,000 international industry professionals from over 150 countries and 3,000 brands showcasing their products and services.

 

Hosted Buyers

IBTM World pays for the flights and accommodation of selected senior decision makers with top level purchasing responsibility that qualify to benefit from the VIP package. In order to qualify for the latter, they must meet very strict criteria such as annual budget, number of annual events, purchasing power, etc.

A buyer driven matching system enables the Hosted Buyers to schedule appointments with selected exhibitors in advance.

 

Exhibitors

These are the suppliers to the meetings and incentives industry. They come from various sectors including: Airlines & Cruiselines, Attractions, Conference & Meeting Venues, Convention Bureaux, Destination Management Services, Hotels, Incentive Destinations, Travel Management Companies, etc.

 

Trade Visitors

They are decision makers who organise meetings, conferences, events, as well as business travel programs and include Agencies, Associations, Corporations, Professional Conference Organisers, etc.

 

Event Programme

There will be plenty of things to see and do during the three day event. For a more detailed view, you can access the show’s preview here.

cb-01

We will also be there to showcase our booking offers for medical congresses in 2018!

Best price, best rooms, best location for medical congresses worldwide!

In the world of MICE (Meetings, Incentives, Conferences and Events), Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses in 2018, regardless of their location. We operate internationally!

  • EASL 2018 – 210 rooms in seven 4-star hotels
  • EAACI 2018 – 615 rooms in fourteen 4-star hotels
  • EHA 2018 – 1200 rooms in thirty 4-star hotels
  • ERS 2018 – 615 rooms in twenty 4-star hotels
  • EURETINA 2018 – 460 rooms in twelve 4-star hotels
  • EASD 2018 – 765 rooms in sixteen 4-star hotels
  • ECTRIMS 2018 – 620 rooms in ten hotels
  • ESMO 2018 – 1092 rooms in twenty-one 4-star hotels.

And many more!

Advertisements

Let’s Meet at IMEX in Frankfurt and Discuss the Most Important 2018 Congresses

imex frankfurt 2017 logo

 

Next week, between 16-18 May, Frankfurt hosts one of the largest meetings industry trade shows, IMEX, the event where “the air is electric”.

IMEX in Frankfurt is meant for business professionals, providing unique business opportunities for exhibitors and buyers alike. Planners who want to book and organise worldwide meetings, events and incentive travel programs have the opportunity to access everything in one place next week.

Event Attendees

Over 3500 exhibitors come to IMEX every year. If you’re in the meetings industry, this is the show for you!

Buyers spanning various industry segments

Agencies – besides business and conference travel agencies, full-service incentive houses, conference organizers, sales and promotion agencies, as well as marketing, PR and advertising agencies will attend the trade show.

Associations – US-based or international congress, conventions and meeting organizers.

Corporates – these are represented by executives of companies dealing with meetings, conferences and incentive travel programs.

Exhibitors showcasing their offers

These include both US-based domestic suppliers as well as international tourist offices and convention bureaus, big hotel companies, different conference and exhibition centers, cruise lines, airlines, event management specialists and many more.

cb-01

We will also be there to showcase our booking offers for medical congresses in 2018. Let’s meet!

Best price, best rooms, best location for medical congresses worldwide!

In the world of MICE (Meetings, Incentives, Conferences and Events), Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses in 2018, regardless of their location. We operate internationally!

  • EASL 2018 – 210 rooms in seven 4-star hotels
  • EAACI 2018 – 615 rooms in fourteen 4-star hotels
  • EHA 2018 – 1200 rooms in thirty 4-star hotels
  • ERS 2018 – 615 rooms in twenty 4-star hotels
  • EURETINA 2018 – 460 rooms in twelve 4-star hotels
  • EASD 2018 – 765 rooms in sixteen 4-star hotels
  • ECTRIMS 2018 – 620 rooms in ten hotels
  • ESMO 2018 – 1092 rooms in twenty-one 4-star hotels.

And many more!

EPA 2018 & 3 Things to Do While in Nice

This article is brought to you by Congress Bookers, a reliable accommodation partner for lead pharma companies worldwide.

Founded in 1983, the European Psychiatric Association is the number one association representing psychiatry in Europe. It has active individual members in 88 countries and 40 National Society/Association Members representing over 78000 European psychiatrists. EPA’s mission is to improve mental health care and psychiatry in Europe.

In 2018, EPA’s 26th European Congress of Psychiatry takes place in Nice between 3-6 March. The timetable and the programme are still work in progress. You can submit your proposal here. The congress promises to bring together expert clinical psychiatrists, researchers and leaders of stakeholder organizations in the field of mental health. The theme of the 26th edition will be Mental Health: Integrate, Innovate, Individualise.

 

Key Dates

  • Program Proposal Deadline: 10 May 2017
  • Abstract Submission Deadline: 26 Sept. 2017
  • Travel Grant Deadline: 26 Sept. 2017
  • Early Registration Deadline: 10 January 2018

Is EPA’s 26th European Congress of Psychiatry on your list in 2018? Give us a sign and we’ll handle your accommodation needs in a fast and reliable way!

 

Things to do while in Nice

Nice-France

Although Nice is the second-largest French city on the Mediterranean coast and the second-largest city in the Provence-Alpes-Côte d’Azur region after Marseille, the city is seen as the unofficial capital of the Côte d’Azur.

 

Enjoy a relaxing walk on Promenade des Anglais

The Promenade des Anglais is probably the most famous stretch of seafront in France, along the Mediterranean and extending from the airport on the west to the Quai des États-Unis on the east, over a distance of approximately 7 km. The promenade got its name from the English expat patrons who paid for it in 1822.

You can either choose to take a long walk and enjoy the sea breeze, rent skates, scooters and bikes from Roller Station or cruise along in an electric Segway from Mobilboard Nice.

Some of the promenade’s landmarks are the Hôtel Negresco, the art-deco Palais de la Méditerranée and Niçoise sculptor Sabine Géraudie’s giant iron sculpture La Chaise de SAB.

In 2015, the Promenade des Anglais was submitted as a candidate for the Unesco World Heritage status.

Connect with the past through art

Visit the Musée de Paléontologie Humaine de Terra Amata which was built on the site of a prehistoric settlement and where you can explore life on the Riviera 400,000 years ago through a variety of prehistoric artefacts.

You can also deep dive into the artistic movement and its history by admiring some 600 artworks at the Musée International d’Art Naïf Anatole Jakovsky. The building houses the Musée des Beaux-Arts, which is in itself a work of art and where you can gaze at pieces ranging from 15th century altar objects to Rodin’s imposing sculpture ‘The Kiss’. Artists represented include Chéret, Fragonard, Braque, Carrière, Chagall, Degas, Monet, Sisley, sculptures by Carpeaux and Rodin as well as pottery by Picasso. The museum also houses the Dufy painting collection and the Alexis and Gustav Adolf Mossa art collections.

 

Experience Nice to the fullest in the Old Town

The maze of narrow alleyways with restaurants, boutiques and bars give the picturesque Old Town of Nice a lively ambience reminiscent of Italy.

The layout hasn’t changed much over the past 3 centuries and the main piece is Cours Saleya, a huge market square that’s absolutely packed in summer. The food, flea and flower markets will delight your senses and make you fall in love with everything French.

A few steps away from the Cours Saleya is the Galerie des Ponchettes, a museum dedicated to the art work of Raoul Dufy. Also near the Cours Saleya is the Palais Lascaris, a Baroque palace from the 17th century that was the home of the Lascaris-Vintimille family, the Counts of Castellar.

Is EPA’s 26th European Congress of Psychiatry on your list in 2018? Give us a sign and we’ll handle your accommodation needs in a fast and reliable way!

Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses, regardless of their location.

Deep Learning in Drug Discovery & Companies That Provide It

This article is brought to you by Congress Bookers, a reliable accommodation partner for lead pharma companies worldwide.

In order to better understand the meaning of deep learning, we first need to take a look at big data.

 

Big Data

New technologies such as the internet of things (IoT) and genomics generate huge data sets in a completely unstructured manner which are referred to as big data. These data sets are so large and so complex that they can’t be analysed using traditional apps and software. Therefore, new applications emerge. One of the biggest players in the field is Palantir Technologies, a company which helps make sense of all this big data. While storing this data is one thing, analyzing it is something completely different and it takes us to the concept of deep learning.

 

Deep Learning

Deep learning involves teaching a computer to make sense of all the unstructured big data using various methods like “artificial neural networks” which mimic the way the human brain works. What it does is use algorithms to search for complex relationships in all that “big data.”Those algorithms are constantly refined and improved.

Cognitive computing refers to a computer’s ability to learn more over time based on experience, much like the human brain does. You’ve probably read some articles on IBM’s Watson cognitive computing platform that uses deep learning for translation, speech-to-text, and text-to-speech. Deep learning or cognitive computing is a form of artificial intelligence.

Deep Learning & Drug Discovery

As explained so far, deep learning is a way to analyse big data and find relationships within huge data sets that would take years and years for humans to discover and process on their own.

If we see this in the context of the drug discovery industry, many years of research are needed to identify a drug compound that might be effective in combating a disease prior to seeking FDA approval. The FDA approval process is actually more like the cherry on top, it comes after huge research and extended trials. All this translates into billions spent by the pharmaceutical industry

on R&D with the aim of discovering compounds that treat specific diseases. Unfortunately, the path is long and rocky leading to only a fraction of all that research translated into commercial drugs.

Deep learning could make things faster and much more efficient by analysing a wide spectrum of already effective molecular compounds and use the findings to develop new drugs to combat diseases.

Some companies have turned to deep learning in an attempt to shorten the drug discovery cycle by building platforms that enable the discovery of new drug compounds, while predicting their likely success.

 

Atomwise

Founded in 2012, US-based deep learning company Atomwise is the creator of AtomNet, the first deep learning technology for novel small molecule discovery, characterized by its unprecedented speed, accuracy, and diversity. The company has worked with companies like Merck and has been involved in Ebola treatment research.

 

Insilico Medicine

Founded in 2014, Insilico Medicine raised USD 10M in a venture round in February 2017. The company is dedicated to finding novel solutions for cancer, aging and age-related diseases using advances in genomics and big data analysis. They provide services like advanced deep learning, custom drug and biomarkers discovery, aging research tools to academia, pharma and cosmetics companies.

 

Berg Health

Berg Health is a Boston-based biopharma company founded in 2006. They use their “Berg Interrogative Biology™ discovery platform” to reduce the time, and expense, of drug development. Berg focuses on three distinct areas: diagnostics, pharmaceutical research and development and health care analytics.

 

twoXAR

Founded in 2014, twoXAR is “an artificial intelligence-driven drug discovery company.” Using its computational platform, twoXAR identifies promising drug candidates, lowers risks through preclinical studies, and progresses drug candidates to the clinic through industry and investor partnerships. Their DUMA Drug Discovery platform evaluates enormous datasets to identify and rank high probability drug-disease matches in minutes rather than years.

Using deep learning for drug discovery is still in its early stages but it definitely shows great promise. By teaching a computer how to learn, relationships between vast data sets are uncovered thus helping scientists and researchers learn more about how to treat diseases whether they’re new or have been around for decades.

cb-01

Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses in 2017, regardless of their location. The biggest congresses next year are:

Top Pharma News & Developments that Made Headlines in March

These are last month’s pharma news and developments brought to you by Congress Bookers, a reliable accommodation partner for lead pharma companies worldwide.

 

FDA approved Roche’s OCREVUS

roche

The US Food and Drug Administration (FDA) approved Roche’s OCREVUS (ocrelizumab) for relapsing and primary progressive forms of multiple sclerosis (MS).

OCREVUS reduced relapses per year by half during the two RMS Phase III studies. Furthermore, in a separate PPMS Phase III study, OCREVUS was the first and only treatment to significantly slow disability progression and reduce signs of disease activity in the brain compared with placebo with a median follow-up of three years.

The European Medicines Agency (EMA) has validated OCREVUS’ Marketing Authorisation Application (MAA) which is currently under review.

 

AstraZeneca Partnered with Circassia

astrazeneca-svg

AstraZeneca entered a strategic collaboration with respiratory biopharmaceutical company Circassia Pharmaceuticals plc. The agreement was signed for the development and commercialisation of inhaled respiratory medicines Tudorza and Duaklir in the US.

Tudorza and Duaklir are used for the treatment of chronic obstructive pulmonary disease (COPD). While Tudorza was launched in the US in 2012, Duaklir will be submitted for US regulatory review in 2018.

Under the agreement, AstraZeneca will receive a minority equity stake in Circassia while the latter will lead the promotion of Tudorza and was granted the rights to Duaklir in the US. AstraZeneca will complete ongoing development activities and continue to manufacture and supply both medicines.

 

MedImmune Formed Alliance with Sanofi Pasteur for MEDI8897

Impression

MedImmune, the global biologics research and development arm of AstraZeneca, and Sanofi Pasteur, the vaccines division of Sanofi, have formed an alliance to develop and commercialise potential next-generation respiratory syncytial virus antibody MEDI8897.

The two companies will jointly develop and commercialise MEDI8897, a monoclonal antibody (mAb) for the prevention of lower respiratory tract illness (LRTI) caused by respiratory syncytial virus (RSV).

MedImmune and Sanofi Pasteur will equally share all costs and profits.

 

Mylan in Global Settlement & License Agreements with Genentech and Roche on Herceptin

Mylan_Logo

In March, Mylan has agreed to the terms of a global settlement with Genentech and Roche in what concerns patents for Herceptin (trastuzumab). This enables Mylan to have global licenses for its trastuzumab product.

Under the agreement, Mylan will be able to commercialize its trastuzumab product in markets worldwide. The licenses pertain to all countries except Japan, Brazil and Mexico.

As part of the settlement, Mylan agreed to withdraw its pending Inter Partes Review (IPR) challenges against two US Genentech patents (patent numbers 6,407,213 and 6,331,415).

 

Boehringer Ingelheim Expanded Its Collaboration with Vanderbilt University

boehringer_ingelheim_logo-svg

Boehringer Ingelheim has entered a collaboration with Vanderbilt University. This adds to an already existing collaboration by focusing on the research and development of small molecule compounds targeting the protein SOS. This molecule activates KRAS and triggers a molecular switch that plays a key role when tackling some of the deadliest types of cancer.

This collaboration has led to discoveries that might set the scene for the development of novel cancer treatment options based on molecules that are able to block this critical cancer driver.

 

Merck’s Keytruda Got FDA Nod for Treating Blood Cancer

merck_logo

Merck got a first approval from the U.S. Food and Drug Administration (FDA) under the accelerated approval program for its immunotherapy drug Keytruda as a treatment for a type of blood cancer. Keytruda is already approved for treating lung, head and neck cancers.

FDA’s accelerated approval program allows for quicker approval of drugs that fill an unmet medical need.

cb-01

Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses in 2017, regardless of their location. The biggest congresses next year are:

3 Reasons to Attend EASD’s Annual Meeting in 2017

The European Association for the Study of Diabetes (EASD) was founded in 1965 as non-profit, medical scientific association based in Duesseldorf, Germany. The Association’s main goal is to support and encourage research in the field of diabetes.

EASD has more than 5,000 active members from over 100 countries worldwide which makes it  one of the largest networks for diabetologists across the globe. Its Annual Meeting is held in a different European city each year. In 2017, the 53rd Annual Meeting of the European Association for the Study of Diabetes will take place in Lisbon, between 11-15 September 2017.

Is the 53rd Annual Meeting of the European Association for the Study of Diabetes on your list in 2017 or/ and 2018? Give us a sign and we’ll handle your accommodation needs in a fast and reliable way!

For 2017.

For 2018.

 

EASD’s Annual Meeting is the Biggest Event of Its Kind

Over 15,000 delegates from more than 130 countries are attending EASD’s Annual Meeting every year. The scientific programme includes over 1,200 talks and presentations on the latest results in diabetes research by leading experts in the field. The Annual Meeting represents a great opportunity for physicians to learn more about diabetes and related diseases, for pharma companies to promote their products and for hotel brokers to showcase their offers. The event is a great opportunity to encounter new vendors and suppliers at the trade show exhibit hall.

 

The Programme Tackles the Hottest Topics in the Field

We’ve visited the event’s website and went through their Programme at a Glance section for the 2017 Annual Meeting. Some key topics that will approached during this year’s event are the following:

  • Management of type 2 diabetes with basal insulin revisited: results of the glargine 300 U/ml Real Life Study Program
  • Cardiovascular complications of diabetes: hot topics
  • Intergenerational transmission of obesity and diabetes: Is the fog being cleared?
  • The beta cell in type 2 diabetes: What are the changes and are they reversible?
  • Molecular transducers of metabolic benefits of exercise
  • Diabetes, obesity, their treatment and cancer risk: smoke or fire?
  • Cognitive impairment and Alzheimer’s disease in the type 2 diabetes patient: from basic science to treatment
  • Genome editing principle and practice: Is there opportunity for diabetes?

 

It’s a Great Opportunity to Visit Lisbon

Successful people know how to mix business with pleasure. It would be a pity to be in Lisbon for the 53rd Annual Meeting of the European Association for the Study of Diabetes and not visit this wonderful city.

Lisbon is Europe’s second oldest capital, predating other modern European capitals such as London, Paris and Rome by centuries. Lisbon is also where the world’s first diabetes association was created in 1926 by Ernesto Roma. You will be enchanted by its rich history, great architecture, old monuments and wonderful landscape. Lisbon is surrounded by beaches, mountains and the countryside. The view is amazing!

Here’s a list with some of the things that you can visit in Lisbon:

  • Saint George’s Castle, a major landmark that can be seen from anywhere in the city.
  • Jerónimos Monastery, a monastery of the military Order of Saint Jerome, an outstanding example of late-Gothic Manueline architecture and is a UNESCO site.
  • Belém Tower, a defense tower completed in 1520 during the reign of Manuel I.
  • Time Out Market Lisboa, home to 35 permanent stalls from some of Lisbon’s most celebrated foodie shops and restaurants.
  • Lisbon Oceanarium, the largest indoor aquarium in Europe.

 

That being said, we hope you’ll enjoy attending EASD’s Annual Meeting in 2017!

Contact us for a personalized accommodation offer for the 53rd Annual Meeting of the European Association for the Study of Diabetes. No strings attached. We usually reply within a few hours.

For 2017.

For 2018.

All You Need to Know about The European Hematology Association and its Annual Congress

The European Hematology Association (EHA) was founded in Belgium in 1992. For the next 6 years, the Association organised a congress in different European cities every two years. Starting 1998, the congress became an annual event taking place in June. Nowadays, the Association’s executive office is located in the Netherlands, with over 3,200 members from 100 countries.

The educational program of the annual congress is based on the European Hematology Curriculum, the main goal of the Association being to lobby for hematology and promote research that supports hematologists in- and outside Europe.

Is the Annual Congress of the European Hematology Association on your list in 2017 or/ and 2018? Give us a sign and we’ll handle your accommodation needs in a fast and reliable way!

For 2017.

For 2018.

 

The Annual Congress

At the EHA Annual Congress, hematologists and affiliated professionals gain access to original unpublished data and ideas regarding hematological innovation. During the congress, they will be able to improve their knowledge and approach regarding evidence-based diagnosis and treatment diseases related to hematology, access research results on hematologic disorders, gain insight about innovative techniques and diagnostic tools, as well as leverage networking opportunities with other medical professionals, patient groups, medical industry and the media.

Besides a program that covers every subspecialty in hematology, the Annual EHA Congress gives attendees the opportunity to network with experts from across the globe. The congress also provides the opportunity to attend satellite programs, updates-in-hematology and to visit the exhibition put together by big pharmaceutical companies.

Between 22-25 June 2017, the EHA is organizing its annual congress in Madrid, Spain. The program will cover 15 tracks as follows: advocacy track, benign hematology, biology, clinical, early career track, general skills, laboratory diagnosis, lymphoid malignancies and plasma cell disorders, myeloid malignancies, pediatric hematology, personalised medicine, stem cell transplantation and special therapy, thrombosis and hemostasis, transfusion medicine, and translational. For a more detailed breakdown of each track, visit this page on their website.

There are 17 sessions that will be covered during this year’s annual congress: basic science in focus, clinical debate, early career session, education session, hematology-in-focus, joint symposium, laboratory diagnosis workshop, late breaking abstracts, meet-the-expert, molecular hemopoiesis workshop, oral presentation, plenary session, poster session, presidential symposium, satellite symposium, scientific working group, special session.

Make sure you know the key dates and other important information.

In 2018, the annual congress will take place in Stockholm, Sweden, between 14-17 June.

Apart from the annual congress, EHA also hosts other significant events meant to support hematologists and improve patient care.

 

Educational Events

Throughout the year, EHA organizes educational courses on the latest developments in hematology. These fall under two main categories: hematology tutorials and highlights of past EHA. In 2017, there is a tutorial on Lymphoid Malignancies in Warsaw, Poland, between 17-18 March and one on Laboratory Hematology between 8-9 April in Çanakkale, Turkey.

The Highlights of Past EHA event will take place in Cairo, Egypt, between 14-16 September 2017. This year, EHA-HOPE, short for Highlights of Past EHA, aims to bring the key messages from various fields of hematology of the 22nd Congress of EHA to the Middle East and North Africa.

 

Scientific Events

The EHA-SWG Scientific Meetings represent a joint collaboration between the EHA Scientific Working Groups (SWGs) and EHA. The meetings aim to provide an innovative format that includes e.g. discussions with patient organizations, regulators and pharma companies.

In 2017, there will be 4 big scientific meetings:

  • The EHA-SWG Scientific Meeting on Rare Lymphomas between 10-12 March, in Barcelona, Spain.
  • The EHA-SWG Scientific Meeting on Aging and Hematology.
  • The EHA-SWG Scientific Meeting on Challenges in the Diagnosis and Management of Myeloproliferative Neoplasms between 12-14 October, 2017.
  • EHA-SWG Scientific Meeting on Shaping the Future of Mesenchymal Stromal Cells Therapy between 23-25 November, 2017.

Contact us for a personalised accommodation offer for the Annual Congress of the European Hematology Association. No strings attached. We usually reply within a few hours.

For 2017.

For 2018.

cb-01

Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses, regardless of their location.